2-(4-Methylpiperazin-1-yl)pyrimidin-5-amine, 95.0%, 5g

2-chloro-5-(3-methoxyphenyl)pyrazine, 95.0%, 250mg

Ácido 4-clorobenzoico, >=98%, para síntesis, 250 g, envase plástico.

4-BROMO-3-(DIFLUOROMETHYL)ANILINE, 95%, 250mg

3-(DIFLUOROMETHYL)-1H-PYRAZOL-4-AMINE, 95.0%, 100mg

1-Ethynyl-4-(methoxymethoxy)-2-methylbenzene, 98%, 1g

2-Chloro-5-phenyloxazole, 95.0%, 1g

5-BROMO-7-NITRO-1H-INDAZOLE, 95%, 100mg

2-Oxo-1,2-dihydro-quinoline-3-carbaldehyde, 95.0%, 10g

N-(1H-Pyrrolo[2,3-c]pyridin-5-yl)acetamide, 98%, 1g

2-Cyano-3-chloro-5-trifluoromethylpyridine, 98.0%, 100g

6-Chloro-1H-benzo[d]imidazole-2-carboxylic acid, 95.0%, 1g

Ulixertinib, 250mg